- BNS Dashboard
-
Financials
- Filings
- Holdings
- Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
The Bank of Nova Scotia (BNS) Financial statements
Company Profile
Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2020 | Oct 2019 | Oct 2019 | Oct 2018 | Oct 2018 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||
Cost of Revenue | |||||||||||
Gross Profit | |||||||||||
Gross Profit Margin (%) | |||||||||||
R&D Expense | |||||||||||
SG&A Expense | |||||||||||
Total Operating Expenses | |||||||||||
Operating Income or Loss | |||||||||||
Operating Margin (%) | |||||||||||
Interest Expense | |||||||||||
Total Other Income/Expenses | |||||||||||
Income Before Tax | |||||||||||
Income Tax Expense | |||||||||||
Income from Continuing Ops. | |||||||||||
Net Income | |||||||||||
Net Profit Margin (%) | |||||||||||
Net Income Available to Common Shareholders | |||||||||||
Basic EPS | |||||||||||
Diluted EPS | |||||||||||
Basic Average Shares | |||||||||||
Diluted Average Shares |
Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||||||
Cost of Revenue | ||||||||||||||
Gross Profit | ||||||||||||||
Gross Profit Margin (%) | ||||||||||||||
R&D Expense | ||||||||||||||
SG&A Expense | ||||||||||||||
Total Operating Expenses | ||||||||||||||
Operating Income or Loss | ||||||||||||||
Operating Margin (%) | ||||||||||||||
Interest Expense | ||||||||||||||
Total Other Income/Expenses | ||||||||||||||
Income Before Tax | ||||||||||||||
Income Tax Expense | ||||||||||||||
Income from Continuing Ops. | ||||||||||||||
Net Income | ||||||||||||||
Net Profit Margin (%) | ||||||||||||||
Net Income Available to Common Shareholders | ||||||||||||||
Basic EPS | ||||||||||||||
Diluted EPS | ||||||||||||||
Basic Average Shares | ||||||||||||||
Diluted Average Shares |
Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2020 | Oct 2019 | Oct 2019 | Oct 2018 | Oct 2018 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||
Cash & Cash Equivalents | |||||||||||
Marketable Securities | |||||||||||
Receivables | |||||||||||
Inventories | |||||||||||
Other Current Assets | |||||||||||
Total Current Assets | |||||||||||
Non-Current Assets | |||||||||||
Marketable Securities | |||||||||||
PPE Net | |||||||||||
Intangibles inc. Goodwill | |||||||||||
Other Non-Current Assets | |||||||||||
Total Non-Current Assets | |||||||||||
Total Assets | |||||||||||
Current Liabilities | |||||||||||
Accounts Payable | |||||||||||
Deferred Revenues | |||||||||||
Debt, Current | |||||||||||
Accrued Liabilities | |||||||||||
Other Current Liabilities | |||||||||||
Total Current Liabilities | |||||||||||
Non-Current Liabilities | |||||||||||
Deferred Revenues | |||||||||||
Debt, Non-Current | |||||||||||
Other Non-Current Liabilities | |||||||||||
Total Non-Current Liabilities | |||||||||||
Total Liabilities | |||||||||||
Shareholders' Equity | |||||||||||
Common Stock | |||||||||||
Additional Paid-In Capital | |||||||||||
Retained Earnings | |||||||||||
Other Shareholders' Equity | |||||||||||
Total Shareholders' Equity | |||||||||||
Total Liabilities & Shareholders' Equity |
Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||||||
Cash & Cash Equivalents | ||||||||||||||
Marketable Securities | ||||||||||||||
Receivables | ||||||||||||||
Inventories | ||||||||||||||
Other Current Assets | ||||||||||||||
Total Current Assets | ||||||||||||||
Non-Current Assets | ||||||||||||||
Marketable Securities | ||||||||||||||
PPE Net | ||||||||||||||
Intangibles inc. Goodwill | ||||||||||||||
Other Non-Current Assets | ||||||||||||||
Total Non-Current Assets | ||||||||||||||
Total Assets | ||||||||||||||
Current Liabilities | ||||||||||||||
Accounts Payable | ||||||||||||||
Deferred Revenues | ||||||||||||||
Debt, Current | ||||||||||||||
Accrued Liabilities | ||||||||||||||
Other Current Liabilities | ||||||||||||||
Total Current Liabilities | ||||||||||||||
Non-Current Liabilities | ||||||||||||||
Deferred Revenues | ||||||||||||||
Debt, Non-Current | ||||||||||||||
Other Non-Current Liabilities | ||||||||||||||
Total Non-Current Liabilities | ||||||||||||||
Total Liabilities | ||||||||||||||
Shareholders' Equity | ||||||||||||||
Common Stock | ||||||||||||||
Additional Paid-In Capital | ||||||||||||||
Retained Earnings | ||||||||||||||
Other Shareholders' Equity | ||||||||||||||
Total Shareholders' Equity | ||||||||||||||
Total Liabilities & Shareholders' Equity |
Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2020 | Oct 2019 | Oct 2019 | Oct 2018 | Oct 2018 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||
Net Income | |||||||||||
Depreciation & Amortization | |||||||||||
Deferred Income Taxes | |||||||||||
Stock Based Compensation | |||||||||||
Accounts Receivable | |||||||||||
Inventory | |||||||||||
Accounts Payable | |||||||||||
Deferred Revenue | |||||||||||
Other Non-Cash | |||||||||||
Operating Cash Flow | |||||||||||
Cash Flows from Investing Activities | |||||||||||
PPE Investments | |||||||||||
Net Acquisitions | |||||||||||
Purchase of Investments | |||||||||||
Sale of Investments | |||||||||||
Other Investing Activity | |||||||||||
Investing Cash Flow | |||||||||||
Cash Flows from Financing Activities | |||||||||||
Debt Issued | |||||||||||
Proceeds from Debt Repayment | |||||||||||
Debt Repayment | |||||||||||
Proceeds from Sale of Equity | |||||||||||
Equity Repurchased | |||||||||||
Dividend Paid | |||||||||||
Other Financing Activity | |||||||||||
Financing Cash Flow | |||||||||||
Cash Position | |||||||||||
Beginning Cash Position | |||||||||||
End Cash Position | |||||||||||
Change in Cash | |||||||||||
Free Cash Flow | |||||||||||
Operating Cash Flow | |||||||||||
Capital Expenditure | |||||||||||
Free Cash Flow |
Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||||
Net Income | ||||||||||||||
Depreciation & Amortization | ||||||||||||||
Deferred Income Taxes | ||||||||||||||
Stock Based Compensation | ||||||||||||||
Accounts Receivable | ||||||||||||||
Inventory | ||||||||||||||
Accounts Payable | ||||||||||||||
Deferred Revenue | ||||||||||||||
Other Non-Cash | ||||||||||||||
Operating Cash Flow | ||||||||||||||
Cash Flows from Investing Activities | ||||||||||||||
PPE Investments | ||||||||||||||
Net Acquisitions | ||||||||||||||
Purchase of Investments | ||||||||||||||
Sale of Investments | ||||||||||||||
Other Investing Activity | ||||||||||||||
Investing Cash Flow | ||||||||||||||
Cash Flows from Financing Activities | ||||||||||||||
Debt Issued | ||||||||||||||
Proceeds from Debt Repayment | ||||||||||||||
Debt Repayment | ||||||||||||||
Proceeds from Sale of Equity | ||||||||||||||
Equity Repurchased | ||||||||||||||
Dividend Paid | ||||||||||||||
Other Financing Activity | ||||||||||||||
Financing Cash Flow | ||||||||||||||
Cash Position | ||||||||||||||
Beginning Cash Position | ||||||||||||||
End Cash Position | ||||||||||||||
Change in Cash | ||||||||||||||
Free Cash Flow | ||||||||||||||
Operating Cash Flow | ||||||||||||||
Capital Expenditure | ||||||||||||||
Free Cash Flow |